Efficacy of Bravecto® Plus spot-on solution for cats (280 mg/ml fluralaner and 14 mg/ml moxidectin) in the prevention of feline Aelurostrongylus abstrusus infection evaluated in a multi-diagnostic approach
Article in Parasites & Vectors (April 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Efficacy of a spot-on formulation containing 280 mg/ml fluralaner and 14 mg/ml moxidectin (Bravecto® Plus) in the prevention of cat aelurostrongylosis under field conditions
Article in Veterinary Parasitology (January 2024)
Safety of topical administration of fluralaner plus moxidectin concurrently with praziquantel in cats
Article in Parasites & Vectors (November 2018)